Home › Funds › T. Rowe Price › T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund
Fund family: T. Rowe Price · Filed by T. Rowe Price Integrated Equity Funds, Inc. (CIK 1038469) · SEC series S000052904
Share classes and tickers: TQSAX (C000166440), TQSIX (C000166441), TQSMX (C000166439)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 3,192 with, 20 against, 0 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 1 FOR, 19 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | T. Rowe Price | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 92.3% | 3,115 | 93.7% | 208,710 |
| Backed environmental and social shareholder proposals at US companies | n/a | 2 | 2.6% | 3,333 |
Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most T. Rowe Price funds on 35 items (1.2% of the 3,006 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most T. Rowe Price funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Birkenstock Holding Plc | 2026-04-29 | Amend Articles of Association | For | AGAINST — 11 of 14 T. Rowe Price funds | For | — |
| Birkenstock Holding Plc | 2026-04-29 | Elect Director Ruth Kennedy | For | AGAINST — 11 of 14 T. Rowe Price funds | For | — |
| Cytokinetics, Incorporated | 2026-05-27 | 2 wordings Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D. | Withhold | FOR — 15 of 22 T. Rowe Price funds | Against | Passed (calculated), 97.0% support |
| Service Corporation International | 2026-05-06 | Election of Directors: Marcus A. Watts | For | AGAINST — 12 of 18 T. Rowe Price funds | For | Failed (calculated), 43.5% support |
| Service Corporation International | 2026-05-06 | To approve the 2026 Equity Incentive Plan. | Against | FOR — 12 of 18 T. Rowe Price funds | Against | Approved, 78.1% support |
| Element Solutions Inc | 2026-05-04 | Election of Directors: E. Stanley O'Neal | For | AGAINST — 7 of 10 T. Rowe Price funds | For | Passed (calculated), 94.2% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Abid Rizvi | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.8% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Alissa Ahlman | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.8% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Mary Baglivo | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.8% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Richard Zannino | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 95.8% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Robert Fisch | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.3% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Stanley Fleishman | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 90.7% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Stephen White | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.5% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Thomas Hendrickson | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.0% support |
| Element Solutions Inc | 2026-05-04 | Advisory vote to approve the Company's 2025 executive compensation | Against | FOR — 8 of 13 T. Rowe Price funds | Against | Failed (calculated), 41.4% support |
| Dutch Bros Inc. | 2026-05-13 | Election of Directors: Todd Penegor | For | AGAINST — 10 of 17 T. Rowe Price funds | For | Elected, 91.7% support |
| Dutch Bros Inc. | 2026-05-13 | Election of Directors: Travis Boersma | For | AGAINST — 10 of 17 T. Rowe Price funds | For | Elected, 95.6% support |
| Almonty Industries Inc. | 2026-06-09 | Elect Director Andrew Frazer | For | AGAINST — 9 of 15 T. Rowe Price funds | For | — |
| Almonty Industries Inc. | 2026-06-09 | Elect Director Daniel D'Amato | For | AGAINST — 9 of 15 T. Rowe Price funds | For | — |
| Almonty Industries Inc. | 2026-06-09 | Elect Director David Hanick | For | AGAINST — 9 of 15 T. Rowe Price funds | For | — |
| Almonty Industries Inc. | 2026-06-09 | Elect Director Lewis Black | For | AGAINST — 9 of 15 T. Rowe Price funds | For | — |
| Almonty Industries Inc. | 2026-06-09 | Elect Director Mark Trachuk | For | AGAINST — 9 of 15 T. Rowe Price funds | For | — |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Amin N. Maredia | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 98.7% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Edward N. Antoian | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 97.6% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Harry S. Cherken, Jr. | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 98.4% support |
| Company | Meeting | Item | This fund | Most T. Rowe Price funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: John C. Mulliken | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 97.7% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Kelly Campbell | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 99.3% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Mary C. Egan | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 98.7% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Todd R. Morgenfeld | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 99.1% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Wesley S. McDonald | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 98.3% support |
| MapLight Therapeutics, Inc. | 2026-06-23 | To elect the three Class I Director nominees named in the Proxy Statement to serve until the 2029 annual meeting of our stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Martin Babler | For | WITHHOLD — 8 of 14 T. Rowe Price funds | For | — |
| Xenon Pharmaceuticals Inc. | 2026-06-02 | To approve the Corporation's 2026 Equity Incentive Plan; | Against | FOR — 7 of 12 T. Rowe Price funds | Against | Approved, 68.0% support |
| Kodiak Sciences Inc. | 2026-06-02 | Elect three Class II directors nominated by our board and named in this proxy statement: Charles A. Bancroft | For | WITHHOLD — 8 of 15 T. Rowe Price funds | For | Elected, 78.7% support |
| Denali Therapeutics Inc. | 2026-06-03 | ELECTION OF DIRECTORS: David Schenkein, M.D. | For | WITHHOLD — 8 of 15 T. Rowe Price funds | For | Elected, 73.5% support |
| Denali Therapeutics Inc. | 2026-06-03 | ELECTION OF DIRECTORS: Jennifer Cook | For | WITHHOLD — 8 of 15 T. Rowe Price funds | For | Elected, 60.9% support |
Download all 35 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 90.8% of this fund’s 3,212 such votes could be given a sector; the other 297 (9.2%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 585 | 4 | 0.7% |
| Health Care | 527 | 4 | 0.8% |
| Industrials | 526 | 7 | 1.3% |
| Finance | 447 | 2 | 0.4% |
| Technology | 326 | 2 | 0.6% |
| Real Estate | 240 | 0 | 0.0% |
| Energy | 101 | 0 | 0.0% |
| Utilities | 74 | 0 | 0.0% |
| Basic Materials | 27 | 0 | 0.0% |
| Miscellaneous | 26 | 0 | 0.0% |
| Consumer Staples | 25 | 0 | 0.0% |
| Telecommunications | 11 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 2,289 | 0 |
| Audit-related | 345 | 0 |
| Say-on-Pay | 335 | 0 |
| Compensation | 108 | 1 |
| Corporate Governance | 83 | 17 |
| Capital Structure | 48 | 0 |
| Extraordinary Transactions | 20 | 0 |
| Shareholder Rights and Defenses | 10 | 0 |
| Other Social Issues | 2 | 1 |
| Diversity, Equity, and Inclusion | 1 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Tenet Healthcare Corporation | May 27, 2026 | $19M | 14 | 0 |
| Permian Resources Corporation | May 19, 2026 | $14M | 14 | 0 |
| Reliance, Inc. | May 20, 2026 | $14M | 12 | 1 |
| Viatris Inc. | May 15, 2026 | $13M | 15 | 0 |
| East West Bancorp, Inc. | May 18, 2026 | $13M | 15 | 0 |
| BrightSpring Health Services, Inc. | May 21, 2026 | $12M | 5 | 0 |
| Charles River Laboratories International, Inc. | May 5, 2026 | $12M | 15 | 0 |
| Encompass Health Corporation | May 7, 2026 | $11M | 12 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 20, 2026 | Reliance, Inc. | To consider a stockholder proposal requiring any director who fails to receive a majority vote to leave the board of directors within nine months. Shareholder proposal | Against | For |
| May 7, 2026 | Corpay, Inc. | Shareholder proposal regarding an independent Board Chair requirement, if properly presented at the meeting. Shareholder proposal | Against | For |
| May 11, 2026 | MKS Inc. | A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposal | Against | For |
| May 20, 2026 | Quest Diagnostics Incorporated | Stockholder proposal regarding an independent board chairman, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| January 22, 2026 | Jabil Inc. | Vote on a stockholder proposal requesting stockholder right to act by written consent. Shareholder proposal | Against | For |
| May 6, 2026 | Entegris, Inc. | Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposal | Against | For |
| April 28, 2026 | Revvity, Inc. | To approve the shareholder proposal regarding Executives to Retain Significant Stock. Shareholder proposal | Against | For |
| May 21, 2026 | Assurant, Inc. | Stockholder proposal regarding action by written consent. Shareholder proposal | Against | For |
| April 30, 2026 | Global Payments Inc. | Shareholder proposal regarding shareholder right to act by written consent. Shareholder proposal | Against | For |
| May 5, 2026 | Oshkosh Corporation | To vote on a shareholder proposal on the subject of directors who fail to obtain a majority vote. Shareholder proposal | Against | For |
| April 24, 2026 | Stanley Black & Decker, Inc. | To consider and vote on a shareholder proposal requesting an independent Board Chairman. Shareholder proposal | Against | For |
| May 15, 2026 | Medpace Holdings, Inc. | Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. Shareholder proposal | Against | For |
3,242 ballot items at 350 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund (TQSAX) voted at 350 shareholder meetings of 344 companies, on 3,242 ballot items in all. Where management made a recommendation, the fund followed it on 99.4% of the items and voted against it 20 times. Its most frequent area of disagreement was corporate governance (17 of its votes against management). It voted on 20 shareholder proposals. It voted FOR the board's own proposals less often than T. Rowe Price's funds as a whole (92.3% against 93.7%). It voted differently from most T. Rowe Price funds on 35 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.